Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part II: Infections other than malaria

Journal of Travel Medicine

Volumn 14, Issue 1, 2007, Pages 50-60

  Toovey, Stephen ^a,b,d   Moerman, Filip ^c   Van Gompel, Alfons ^c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Travel Clinic   (South Africa)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

A,C,Y,W 135 VACCINE; ANTIBIOTIC AGENT; ARTEMISININ; AZITHROMYCIN; BCG VACCINE; CORTICOSTEROID; DIETHYLTOLUAMIDE; DIMETICONE; ENCEPHALITIS VACCINE; MENINGOCOCCUS VACCINE; METRONIDAZOLE; PRAZIQUANTEL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RIFAXIMIN; ROTAVIRUS VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; AFRICAN TRYPANOSOMIASIS; CHAGAS DISEASE; CHEMOPROPHYLAXIS; CYSTICERCOSIS; DENGUE; EDUCATION; EPIDEMIC ENCEPHALITIS; FILARIASIS; GASTROINTESTINAL DISEASE; GEOGRAPHY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION PREVENTION; LEISHMANIASIS; LIFESTYLE; MENINGOCOCCOSIS; POPULATION DISTRIBUTION; RABIES; REVIEW; RISK FACTOR; RISK MANAGEMENT; SCHISTOSOMIASIS; SCREENING; SELF CARE; STRONGYLOIDIASIS; TRAVEL; TRAVELLER DIARRHEA; TROPICS; TUBERCULIN TEST; TUBERCULOSIS; TYPHOID FEVER; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS INFECTION;

COMMUNICABLE DISEASES; HUMANS; REFUGEES; TRAVEL; TROPICAL CLIMATE; VACCINATION;

EID: 33846308852     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00092.x     Document Type: Review

References (126)

1. Vaccine-preventable diseases, vaccines and vaccination. International Travel and Health. Geneva, Switzerland: World Health Organization, 2005.
2. Steffen R. Changing travel-related global epidemiology of hepatitis A. Am J Med 2005; 118(Suppl 10A):46S-49S.
3. Dijkstra J, Chappuis F, Loutan L. Vaccine-preventable diseases in long-term expatriates. J Travel Med 2005; 12(Suppl 1):S47-S57.
4. Coursaget P, Buisson Y, Enogat N, et al. Outbreak of enterically- transmitted hepatitis due to hepatitis A and hepatitis E viruses. J Hepatol 1998; 28:745-750.
5. Poland GA, Axelsen PH, Felz MW. Hepatitis A and B infections among expatriates in Papua New Guinea: a missed opportunity for immunization. J Travel Med 1996; 3:209-213.
6. Debray D, Cullufi P, Devictor D, et al. Liver failure in children with hepatitis A. Hepatology 1997; 26:1018-1022.
7. Shah U, Habib Z, Kleinman RE. Liver failure attributable to hepatitis A virus infection in a developing country. Pediatrics 2000; 105:436-438.
8. van Gorkom J, Leentvaar-Kuijpers A, Kool JL, Coutinho RA. Annual epidemics of hepatitis A in four large cities related to holiday travel among immigrant children. Ned Tijdschr Geneeskd 1998; 142:1919-1923.
9. Pandey P, Shlim DR, Cave W, Springer MF. Risk of possible exposure to rabies among tourists and foreign residents in Nepal. J Travel Med 2002; 9:127-131.
10. Hatz CF, Bidaux JM, Eichenberger K, et al. Circumstances and management of 72 animal bites among long-term residents in the tropics. Vaccine 1995; 13:811-815.
11. Bernard KW, Fishbein DB. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine 1991; 9:833-836.
12. LeGuerrier P, Pilon PA, Deshaies D, Allard R. Pre-exposure rabies prophylaxis for the international traveller: a decision analysis. Vaccine 1996; 14:167-176.
13. Koch S, Steffen R. Meningococcal disease in travelers: vaccination recommendations. J Travel Med 1994; 1:4-7.
14. Pollard AJ, Shlim DR. Epidemic meningococcal disease and travel. J Travel Med 2002; 9:29-33.
15. Pinner RW, Onyango F, Perkins BA, et al. Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J Infect Dis 1992; 166:359-364.
16. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 2006; 19:142-164.
17. Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine - United States, June-July 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1023-1025.
18. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. MMWR Morb Mortal Wkly Rep 2005; 54:1-21.
19. Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002; 35:183-188.
20. Steffen R, Connor BA. Vaccines in travel health: from risk assessment to priorities. J Travel Med 2005; 12:26-35.
21. Rose MR, Hughes SM, Gatus BJ. A case of Japanese B encephalitis imported into the United Kingdom. J Infect 1983; 6:261-265.
22. Wittesjo B, Eitrem R, Niklasson B, et al. Japanese encephalitis after a 10-day holiday in Bali. Lancet 1995; 345:856-857.
23. Japanese encephalitis in a U.S. traveler returning from Thailand, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:123-125.
24. Solomon T. Japanese encephalitis vaccine. In: Jong E, Zuckerman J, eds. Travelers' vaccines. Hamilton, ON: BC Decker, 2004:219-256.
25. Kuwayama M, Ito M, Takao S, et al. Japanese encephalitis virus in meningitis patients, Japan. Emerg Infect Dis 2005; 11:471-473.
26. Takahashi H, Pool V, Tsai TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. Vaccine 2000; 18:2963-2969.
27. Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003; 188:1213-1230.
28. Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis 2004; 39:186-191.
29. Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134:433-438.
30. Shirakawa T, Acharya B, Kinoshita S, et al. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54:299-303.
31. Ekdahl K, de JB, Andersson Y. Risk of travel-associated typhoid and paratyphoid fevers in various regions. J Travel Med 2005; 12:197-204.
32. Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med 2001; 8:263-266.
33. Struve J, Norrbohm O, Stenbeck J, et al. Risk factors for hepatitis A, B and C virus infection among Swedish expatriates. J Infect 1995; 31:205-209.
34. Cobelens FG, van Schothorst HJ, Wertheim-Van Dillen PM, et al. Epidemiology of hepatitis B infection among expatriates in Nigeria. Clin Infect Dis 2004; 38:370-376.
35. Bonneux L, Van der SP, Taelman H, et al. Risk factors for infection with human immunodeficiency virus among European expatriates in Africa. BMJ 1988; 297:581-584.
36. de Graaf R, van Zessen G, Houweling H, et al. Sexual risk of HIV infection among expatriates posted in AIDS endemic areas. AIDS 1997; 11:1173-1181.
37. Matteelli A, Carosi G. Sexually transmitted diseases in travelers. Clin Infect Dis 2001; 32:1063-1067.
38. Gamester CF, Tilzey AJ, Banatvala JE. Medical students' risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ 1999; 318:158-160.
39. Uslan DZ, Virk A. Postexposure chemoprophylaxis for occupational exposure to HIV in traveling health care workers. J Travel Med 2005; 12:14-18.
40. Kim JC, Martin LJ, Denny L. Rape and HIV postexposure prophylaxis: addressing the dual epidemics in South Africa. Reprod Health Matters 2003; 11:101-112.
41. Cancre N, Gresenguet G, Mbopi-Keou FX, et al. Hepatitis C virus RNA viremia in Central Africa. Emerg Infect Dis 1999; 5:484-485.
42. Wansbrough-Jones MH, Frimpong E, Cant B, et al. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg 1998; 92:496-499.
43. Alter MJ, Seeff LB, Bacon BR, et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004; 141:715-717.
44. Bollepalli S, Wisinger D, Markov M, et al. Travel: a unique risk factor for acute hepatitis C virus. 2006. Available at: http://www.medscape.com/ viewarticle/527443. (Accessed 2006 May 22)
45. Green ST. Medical student electives and infectious diseases. Risk of hepatitis C is greater than HIV. BMJ 1999; 318:1146.
46. Jaureguiberry S, Grandiere-Perez L, Ansart S, et al. Acute hepatitis C virus infection after a travel in India. J Travel Med 2005; 12:55-56.
47. Pohjanpelto P. Risk factors connected with hepatitis C infections in Finland. Scand J Infect Dis 1992; 24:251-252.
48. Aggarwal R, Kumar R, Pal R, et al. Role of travel as a risk factor for hepatitis E virus infection in a disease-endemic area. Indian J Gastroenterol 2002; 21:14-18.
49. Andenaes S, Lie A, Degre M. Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel. Aviat Space Environ Med 2000; 71:1178-1180.
50. Bulang T, Porst H. Hepatitis E after travel to India - 2 case reports. Z Gastroenterol 2000; 38:249-253.
51. Hadem J, Wedemeyer H, Manns MP. Hepatitis as a travel disease. Internist (Berl) 2004; 45:655-668.
52. Kim SS, Yeo CD, Kim JD, et al. A case of acute hepatitis E with the travel history to an endemic area. Korean J Gastroenterol 2004; 44:342-345.
53. Kitazawa T, Ota Y, Suzuki M, et al. Acute hepatitis E with elevated creatine phosphokinase. Intern Med 2003; 42:899-902.
54. Palmovic D, Lukas D, Vince A, Kurelac I. Hepatitis E in tourists to India. Lijec Vjesn 2002; 124:313-314.
55. Su CW, Wu JC, Huang YS, et al. Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan. J Gastroenterol Hepatol 2002; 17:1187-1191.
56. Ooi WW, Gawoski JM, Yarbough PO, Pankey GA. Hepatitis E seroconversion in United States travelers abroad. Am J Trop Med Hyg 1999; 61:822-824.
57. Potasman I, Koren L, Peterman M, Srugo I. Lack of hepatitis E infection among backpackers to tropical countries. J Travel Med 2000; 7:208-210.
58. Koizumi Y, Isoda N, Sato Y, et al. Infection of a Japanese patient by genotype 4 hepatitis e virus while traveling in Vietnam. J Clin Microbiol 2004; 42:3883-3885.
59. Toole MJ, Claridge F, Anderson DA, et al. Hepatitis E virus infection as a marker for contaminated community drinking water sources in Tibetan villages. Am J Trop Med Hyg 2006; 74:250-254.
60. Shlim DR, Innis BL. Hepatitis E vaccine for travelers? J Travel Med 2000; 7:167-169.
61. Kumar A, Beniwal M, Kar P, et al. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004; 85:240-244.
62. Peron JM, Mansuy JM, Poirson H, et al. Acute hepatitis during pregnancy: hepatitis E virus must be considered. Gastroenterol Clin Biol 2005; 29:87.
63. Shaikh A, Nelson-Piercy C. Fulminant liver failure following hepatitis E in pregnancy. J Obstet Gynaecol 2006; 26:159-160.
64. Blanchard TJ. Schistosomiasis. Travel Med Infect Dis 2004; 2:5-11.
65. Clerinx J, van Gompel A, Lynen L, Ceulemans B. Early neuroschistosomiasis complicating Katayama syndrome. Emerg Infect Dis 2006; 12:1465-1466.
66. Mackowiak PA. Photo quiz. Clin Infect Dis 2001; 32:1347.
67. Bierman WFW, Wetsteyn JCFM, van Gool T. Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology. J Travel Med 2005; 12:9-13.
68. Cetron MS, Chitsulo L, Sullivan JJ, et al. Schistosomiasis in Lake Malawi. Lancet 1996; 348:1274-1278.
69. Trachtenberg JD, Jacobson M, Noh JC, et al. Schistosomiasis in expatriates in the Arusha region of Tanzania. J Travel Med 2002; 9:233-235.
70. Vreeburg AE, Smit AM, de GA. Schistosomiasis mansoni as an imported disease in The Netherlands. Ned Tijdschr Geneeskd 1987; 131:2305-2308.
71. Cooper E, Iqbal A, Bartlett A, et al. A comparison of topical formulations for the prevention of human schistosomiasis. J Pharm Pharmacol 2004; 56:957-962.
72. Xiao SH, Tanner M, N'Goran EK, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 2002; 82:175-181.
73. Whitty CJ, Mabey DC, Armstrong M, et al. Presentation and outcome of 1107 cases of schistosomiasis from Africa diagnosed in a non-endemic country. Trans R Soc Trop Med Hyg 2000; 94:531-534.
74. Harries AD, Fryatt R, Walker J, et al. Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet 1986; 1:86-88.
75. Cobelens FG, van DH, Draayer-Jansen IW, et al. Association of tuberculin sensitivity in Dutch adults with history of travel to areas of with a high incidence of tuberculosis. Clin Infect Dis 2001; 33:300-304.
76. Cobelens FG, van DH, Draayer-Jansen IW, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000; 356:461-465.
77. Johnston VJ, Grant AD. Tuberculosis in travellers. Travel Med Infect Dis 2003; 1:205-212.
78. Al-Jahdali H, Memish ZA, Menzies D. Tuberculosis in association with travel. Int J Antimicrob Agents 2003; 21:125-130.
79. Cobelens FG, Draayer-Jansen EW, Schepp-Beelen JC, et al. Limited tuberculin screening participation amongst travellers to countries with high tuberculosis incidence; reason to consider BCG vaccination for some travellers. Ned Tijdschr Geneeskd 2003; 147:561-565.
80. Shlim DR, Hoge CW, Rajah R, et al. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence. Clin Infect Dis 1999; 29:613-616.
81. Gaudio PA, Echeverria P, Hoge CW, et al. Diarrhea among expatriate residents in Thailand: correlation between reduced Campylobacter prevalence and longer duration of stay. J Travel Med 1996; 3:77-79.
82. Speelman P, Struelens MJ, Sanyal SC, Glass RI. Detection of Campylobacter jejuni and other potential pathogens in travellers' diarrhoea in Bangladesh. Scand J Gastroenterol Suppl 1983; 84:19-23.
83. Brewster SJ, Taylor DN. Epidemiology of travelers' diarrhea. In: Keystone JS, Kozarsky P, Freedman DO, Nothdurft HD, eds. Travel medicine. 1st ed. Philadelphia: Mosby, 2004:174-184.
84. Hoge CW, Shlim DR, Echeverria P, et al. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA 1996; 275:533-538.
85. Yates J. Traveler' s diarrhea. Am Fam Physician 2005; 71:2095-2100.
86. Brickfield FX, Gebreegzi M, Beyene A. Incidence of protozoal diarrheal disease in an expatriate community in Addis Ababa. Ethiop Med J 1996; 34:107-115.
87. Haberberger RL Jr, Lissner CR, Podgore JK, et al. Etiology of acute diarrhea among United States Embassy personnel and dependents in Cairo, Egypt. Am J Trop Med Hyg 1994; 51:870-874.
88. Fryauff DJ, Krippner R, Prodjodipuro P, et al. Cyclospora cayetanensis among expatriate and indigenous populations of West Java, Indonesia. Emerg Infect Dis 1999; 5:585-588.
89. Riddle MS, Sanders JW, Putnam SD, Tribble DR. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg 2006; 74:891-900.
90. Steffen R, Kollaritsch H, Fleischer K. Travelers' diarrhea in the new millennium: consensus among experts from German-speaking countries. J Travel Med 2003; 10:38-45.
91. Baker DE. Rifaximin: a nonabsorbed oral antibiotic. Rev Gastroenterol Disord 2005; 5:19-30.
92. Gorbach SL. How to hit the runs for fifty million travelers at risk. Ann Intern Med 2005; 142:861-862.
93. Taylor DN, McKenzie R, Durbin A, et al. Double-blind, placebo-controlled trial to evaluate the use of rifaximin (200mg TID) to prevent diarrhea in volunteers challenged with Shigella flexneri 2a (2457T). American Society of Tropical Medicine and Hygiene 53rd Annual Meeting; 2004 Nov 7; 2005.
94. Kebede A, Verweij J, Dorigo-Zetsma W, et al. Overdiagnosis of amoebiasis in the absence of Entamoeba histolytica among patients presenting with diarrhoea in Wonji and Akaki, Ethiopia. Trans R Soc Trop Med Hyg 2003; 97:305-307.
95. Klipstein FA. Tropical sprue in travelers and expatriates living abroad. Gastroenterology 1981; 80:590-600.
96. Prendki V, Grandiere-Perez L, Ansart S, et al. Tropical sprue in two foreign residents, with evidence of Tropheryma whippelii in one case. J Travel Med 2006; 13:175-177.
97. al-Madani AA, Mahfouz AA. Prevalence of intestinal parasitic infections among Asian female house keepers in Abha District, Saudi Arabia. Southeast Asian J Trop Med Public Health 1995; 26:135-137.
98. Becker SI, Smalligan RD, Frame JD, et al. Risk of Helicobacter pylori infection among long-term residents in developing countries. Am J Trop Med Hyg 1999; 60:267-270.
99. McKeag S, Jones M, Burns S. Seroprevalence of Helicobacter pylori infection in long term expatriates. 8th Conference of the International Society of Travel Medicine; 2003 May 7; 2003.
100. McNulty C, Teare L, Owen R, et al. Test and treat for dyspepsia - but which test? BMJ 2005; 330:105-106.
101. Gill GV, Beeching NJ, Khoo S, et al. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg 2004; 98:382-386.
102. Fryatt RJ, Teng J, Harries AD, et al. Intestinal helminthiasis in expatriates returning to Britain from the tropics. A controlled study. Trop Geogr Med 1990; 42:119-122.
103. Sudarshi S, Stumpfle R, Armstrong M, et al. Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country. Trop Med Int Health 2003; 8:728-732.
104. Leutscher P, Andriantsimahavandy A. Cysticercosis in Peace Corps volunteers in Madagascar. N Engl J Med 2004; 350:311-312.
105. Hira PR, Francis I, Abdella NA, et al. Cysticercosis: imported and autochthonous infections in Kuwait. Trans R Soc Trop Med Hyg 2004; 98:233-239.
106. Dorny P, Brandt J, Zoli A, Geerts S. Immunodiagnostic tools for human and porcine cysticercosis. Acta Trop 2003; 87:79-86.
107. Marlet MV, Sang DK, Ritmeijer K, et al. Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. Trans R Soc Trop Med Hyg 2003; 97:515-518.
108. Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med 2003; 49:50-54.
109. Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med 1993; 118:779-784.
110. Cahill J, Shipton L. An overview of returned travelers in Rhode Island. 8th Conference of the International Society of Travel Medicine; 2003 May 7; 2003.
111. Doherty JF, Grant AD, Bryceson AD. Fever as the presenting complaint of travellers returning from the tropics. QJM 1995; 88:277-281.
112. Subirats M, Bru F, Perez-Blasquez E, et al. Onchocerciasis in travelers: 14 cases. 8th Conference of the International Society of Travel Medicine; 2003 May 7; 2003.
113. McCarthy JS, Ottesen EA, Nutman TB. Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis 1994; 170:736-741.
114. Churchill DR, Morris C, Fakoya A, et al. Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K. J Infect 1996; 33:103-109.
115. Janisch T, Preiser W, Berger A, et al. Emerging viral pathogens in long-term expatriates (II): dengue virus. Trop Med Int Health 1997; 2:934-940.
116. Wichmann O, Jelinek T. Dengue in travelers: a review. J Travel Med 2004; 11:161-170.
117. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
118. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1:92-100.
119. Barbosa PRB. The oral transmission of Chagas' disease: an acute form of infection responsible for regional outbreaks. Int J Cardiol 2006; 112:132-133.
120. Chretien JP, Smoak BL. African trypanosomiasis: changing epidemiology and consequences. Curr Infect Dis Rep 2005; 7:54-60.
121. Landron C, Roblot F, Le MG, Becq-Giraudon B. African trypanosomiasis acquired in an urban area. Eur J Intern Med 2003; 14:390-391.
122. Robays J, Ebeja KA, Lutumba P, et al. Human African trypanosomiasis amongst urban residents in Kinshasa: a case-control study. Trop Med Int Health 2004; 9:869-875.
123. McKendrick M. Infectious diseases and the returning traveller - experience from a regional infectious diseases unit over 20 years. J Appl Microbiol 2003; 94(Suppl):25S-30S.
124. Edwards CN, Levett PN. Prevention and treatment of leptospirosis. Expert Rev Anti Infect Ther 2004; 2:293-298.
125. van Gompel A. Screening the asymptomatic returnee. 9th Conference of the International Society of Travel Medicine; 2005 May 4; 2005.
126. Clerinx L, van Gompel A. Post-travel screening In: Keystone JS, Kozarsky P, Freedman DO, Nothdurft HD, Connor BA, eds. Travel medicine. Philadelphia, PA: Elsevier, Mosby; 2004:473-480.